Austin Chemical is a specialist provider of sales, marketing, and distribution services including import export, storage, shipping and customer invoicing. At present the firm distributes more than 8,000 products to over 1,300 end users worldwide on behalf of 115 client companies.
Akron Biotech, which is focused on the production of drug raw materials for next generation pharmaceutical and biotechnology applications, said that through the partnership Austin would supply its full catalogue of products to the drug industry.
These include Akron’s line of bulk animal and human products, chemical reagents, recombinant proteins, monoclonal antibodies for development and serum-free media.
Commenting on the accord, financial terms of which have not been released, Akron CEO Claudia Zylberberg said that: “Akron’s high quality products and Austin’s excellent reputation and established presence creates a mutually beneficial relationship.”
“Austin has been in the business of bridging business and science for over 30 years,” added Austin CEO Samuel Ponticelli.
He went on to say that because Austin “mainly focuses on representing chemical manufacturers, we see changes in the industry, and realize that an expanded biotech products portfolio as offered by a high quality source, like Akron, will answer the demands of our customers.”
The new deal is a further example of Akron’s recent efforts to boost its client base. In December the firm launched the e-commerce section of its website.
At the time sales and marketing director Debra Kezar explained that: "In this economy, it is important to invest in marketing tools that will give you better ROI and will maximize our resources."